Jen­nifer Doud­na, Fy­o­dor Urnov want to stream­line gene edit­ing stud­ies with Dana­her's help

Jen­nifer Doud­na wants to cre­ate a new blue­print for de­vel­op­ing gene edit­ing ther­a­pies for rare dis­eases — an area where there’s been lim­it­ed di­ver­si­ty in the con­di­tions be­ing ad­dressed be­cause many aren’t seen as prof­itable.

The In­no­v­a­tive Ge­nomics In­sti­tute, a non­prof­it found­ed by Doud­na, is part­ner­ing with life sci­ence tools com­pa­ny Dana­her for four years to de­vel­op gene edit­ing ther­a­pies for two rare ge­net­ic dis­eases, and the col­lab­o­ra­tors plan to share their play­book wide­ly in hopes of spurring more de­vel­op­ment of gene edit­ing treat­ments.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER